massarray spectrochip ii Search Results


massarray spectrochips ii  (Sequenom)
90
Sequenom massarray spectrochips ii
(A) CTC viability demonstrated by attachment to 2D Geltrex (Invitrogen)-coated substrate (72 hr after seeding). Isolated CTC were enriched for CD44. No cells were stained for CD45, indicating the absence of WBCs which did not adhere to substrate and were removed after washing with 1X PBS. Some CD44+cells were not stained for Hoechst (white arrows). Scale bar: 20 µm (B) Comparison of CTC isolation and recovery with CellSearch system. (C) Molecular FISH analysis on enriched CTCs of a patient with NSCLC. Cells were stained using Vysis ALK Break Apart FISH probe and counterstained with DAPI. The red and green signals demonstrated a distinct separation of the original fusion signal (arrows), indicating a rearrangement in the 2p23 ALK-gene locus. Scale bar: 16 µm. (D) <t>MassArray</t> spectra for a patient with NSCLC harboring EGFR L747_P753>S. Trace from FFPE, plasma and pooled CTCs illustrated. Percentage indicates calculated proportion of mutant allele against wild type allele (UEP: Unextended primer). ( i ) iPlex bi-allelic spectra on FFPE sample (33% mutant frequency), ( ii ) iPlex bi-allelic spectrum on plasma sample (32% mutant frequency), ( iii ) SABER mutant specific spectrum on plasma sample (Positive – high frequency), ( iv ) SABER mutant specific spectrum on CTCs (Positive – low frequency (n = 3/94), estimated mutant frequency of 1.4%) and ( v ) Representative iPlex & SABER (shown) spectrum on no-template control sample (Negative).
Massarray Spectrochips Ii, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/massarray spectrochips ii/product/Sequenom
Average 90 stars, based on 1 article reviews
massarray spectrochips ii - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
massarray  (Sequenom)
90
Sequenom massarray
(A) CTC viability demonstrated by attachment to 2D Geltrex (Invitrogen)-coated substrate (72 hr after seeding). Isolated CTC were enriched for CD44. No cells were stained for CD45, indicating the absence of WBCs which did not adhere to substrate and were removed after washing with 1X PBS. Some CD44+cells were not stained for Hoechst (white arrows). Scale bar: 20 µm (B) Comparison of CTC isolation and recovery with CellSearch system. (C) Molecular FISH analysis on enriched CTCs of a patient with NSCLC. Cells were stained using Vysis ALK Break Apart FISH probe and counterstained with DAPI. The red and green signals demonstrated a distinct separation of the original fusion signal (arrows), indicating a rearrangement in the 2p23 ALK-gene locus. Scale bar: 16 µm. (D) <t>MassArray</t> spectra for a patient with NSCLC harboring EGFR L747_P753>S. Trace from FFPE, plasma and pooled CTCs illustrated. Percentage indicates calculated proportion of mutant allele against wild type allele (UEP: Unextended primer). ( i ) iPlex bi-allelic spectra on FFPE sample (33% mutant frequency), ( ii ) iPlex bi-allelic spectrum on plasma sample (32% mutant frequency), ( iii ) SABER mutant specific spectrum on plasma sample (Positive – high frequency), ( iv ) SABER mutant specific spectrum on CTCs (Positive – low frequency (n = 3/94), estimated mutant frequency of 1.4%) and ( v ) Representative iPlex & SABER (shown) spectrum on no-template control sample (Negative).
Massarray, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/massarray/product/Sequenom
Average 90 stars, based on 1 article reviews
massarray - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
spectrochip ii arrays  (agena bioscience)
90
agena bioscience spectrochip ii arrays
(A) CTC viability demonstrated by attachment to 2D Geltrex (Invitrogen)-coated substrate (72 hr after seeding). Isolated CTC were enriched for CD44. No cells were stained for CD45, indicating the absence of WBCs which did not adhere to substrate and were removed after washing with 1X PBS. Some CD44+cells were not stained for Hoechst (white arrows). Scale bar: 20 µm (B) Comparison of CTC isolation and recovery with CellSearch system. (C) Molecular FISH analysis on enriched CTCs of a patient with NSCLC. Cells were stained using Vysis ALK Break Apart FISH probe and counterstained with DAPI. The red and green signals demonstrated a distinct separation of the original fusion signal (arrows), indicating a rearrangement in the 2p23 ALK-gene locus. Scale bar: 16 µm. (D) <t>MassArray</t> spectra for a patient with NSCLC harboring EGFR L747_P753>S. Trace from FFPE, plasma and pooled CTCs illustrated. Percentage indicates calculated proportion of mutant allele against wild type allele (UEP: Unextended primer). ( i ) iPlex bi-allelic spectra on FFPE sample (33% mutant frequency), ( ii ) iPlex bi-allelic spectrum on plasma sample (32% mutant frequency), ( iii ) SABER mutant specific spectrum on plasma sample (Positive – high frequency), ( iv ) SABER mutant specific spectrum on CTCs (Positive – low frequency (n = 3/94), estimated mutant frequency of 1.4%) and ( v ) Representative iPlex & SABER (shown) spectrum on no-template control sample (Negative).
Spectrochip Ii Arrays, supplied by agena bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/spectrochip ii arrays/product/agena bioscience
Average 90 stars, based on 1 article reviews
spectrochip ii arrays - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
384 spectrochip ii array  (Sequenom)
90
Sequenom 384 spectrochip ii array
(A) CTC viability demonstrated by attachment to 2D Geltrex (Invitrogen)-coated substrate (72 hr after seeding). Isolated CTC were enriched for CD44. No cells were stained for CD45, indicating the absence of WBCs which did not adhere to substrate and were removed after washing with 1X PBS. Some CD44+cells were not stained for Hoechst (white arrows). Scale bar: 20 µm (B) Comparison of CTC isolation and recovery with CellSearch system. (C) Molecular FISH analysis on enriched CTCs of a patient with NSCLC. Cells were stained using Vysis ALK Break Apart FISH probe and counterstained with DAPI. The red and green signals demonstrated a distinct separation of the original fusion signal (arrows), indicating a rearrangement in the 2p23 ALK-gene locus. Scale bar: 16 µm. (D) <t>MassArray</t> spectra for a patient with NSCLC harboring EGFR L747_P753>S. Trace from FFPE, plasma and pooled CTCs illustrated. Percentage indicates calculated proportion of mutant allele against wild type allele (UEP: Unextended primer). ( i ) iPlex bi-allelic spectra on FFPE sample (33% mutant frequency), ( ii ) iPlex bi-allelic spectrum on plasma sample (32% mutant frequency), ( iii ) SABER mutant specific spectrum on plasma sample (Positive – high frequency), ( iv ) SABER mutant specific spectrum on CTCs (Positive – low frequency (n = 3/94), estimated mutant frequency of 1.4%) and ( v ) Representative iPlex & SABER (shown) spectrum on no-template control sample (Negative).
384 Spectrochip Ii Array, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/384 spectrochip ii array/product/Sequenom
Average 90 stars, based on 1 article reviews
384 spectrochip ii array - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
spectrochip ii  (Sequenom)
90
Sequenom spectrochip ii
(A) CTC viability demonstrated by attachment to 2D Geltrex (Invitrogen)-coated substrate (72 hr after seeding). Isolated CTC were enriched for CD44. No cells were stained for CD45, indicating the absence of WBCs which did not adhere to substrate and were removed after washing with 1X PBS. Some CD44+cells were not stained for Hoechst (white arrows). Scale bar: 20 µm (B) Comparison of CTC isolation and recovery with CellSearch system. (C) Molecular FISH analysis on enriched CTCs of a patient with NSCLC. Cells were stained using Vysis ALK Break Apart FISH probe and counterstained with DAPI. The red and green signals demonstrated a distinct separation of the original fusion signal (arrows), indicating a rearrangement in the 2p23 ALK-gene locus. Scale bar: 16 µm. (D) <t>MassArray</t> spectra for a patient with NSCLC harboring EGFR L747_P753>S. Trace from FFPE, plasma and pooled CTCs illustrated. Percentage indicates calculated proportion of mutant allele against wild type allele (UEP: Unextended primer). ( i ) iPlex bi-allelic spectra on FFPE sample (33% mutant frequency), ( ii ) iPlex bi-allelic spectrum on plasma sample (32% mutant frequency), ( iii ) SABER mutant specific spectrum on plasma sample (Positive – high frequency), ( iv ) SABER mutant specific spectrum on CTCs (Positive – low frequency (n = 3/94), estimated mutant frequency of 1.4%) and ( v ) Representative iPlex & SABER (shown) spectrum on no-template control sample (Negative).
Spectrochip Ii, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/spectrochip ii/product/Sequenom
Average 90 stars, based on 1 article reviews
spectrochip ii - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
spectrochip ii g96  (agena bioscience)
90
agena bioscience spectrochip ii g96
(A) CTC viability demonstrated by attachment to 2D Geltrex (Invitrogen)-coated substrate (72 hr after seeding). Isolated CTC were enriched for CD44. No cells were stained for CD45, indicating the absence of WBCs which did not adhere to substrate and were removed after washing with 1X PBS. Some CD44+cells were not stained for Hoechst (white arrows). Scale bar: 20 µm (B) Comparison of CTC isolation and recovery with CellSearch system. (C) Molecular FISH analysis on enriched CTCs of a patient with NSCLC. Cells were stained using Vysis ALK Break Apart FISH probe and counterstained with DAPI. The red and green signals demonstrated a distinct separation of the original fusion signal (arrows), indicating a rearrangement in the 2p23 ALK-gene locus. Scale bar: 16 µm. (D) <t>MassArray</t> spectra for a patient with NSCLC harboring EGFR L747_P753>S. Trace from FFPE, plasma and pooled CTCs illustrated. Percentage indicates calculated proportion of mutant allele against wild type allele (UEP: Unextended primer). ( i ) iPlex bi-allelic spectra on FFPE sample (33% mutant frequency), ( ii ) iPlex bi-allelic spectrum on plasma sample (32% mutant frequency), ( iii ) SABER mutant specific spectrum on plasma sample (Positive – high frequency), ( iv ) SABER mutant specific spectrum on CTCs (Positive – low frequency (n = 3/94), estimated mutant frequency of 1.4%) and ( v ) Representative iPlex & SABER (shown) spectrum on no-template control sample (Negative).
Spectrochip Ii G96, supplied by agena bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/spectrochip ii g96/product/agena bioscience
Average 90 stars, based on 1 article reviews
spectrochip ii g96 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
massarray rs1000 nanodispenser  (Sequenom)
90
Sequenom massarray rs1000 nanodispenser
(A) CTC viability demonstrated by attachment to 2D Geltrex (Invitrogen)-coated substrate (72 hr after seeding). Isolated CTC were enriched for CD44. No cells were stained for CD45, indicating the absence of WBCs which did not adhere to substrate and were removed after washing with 1X PBS. Some CD44+cells were not stained for Hoechst (white arrows). Scale bar: 20 µm (B) Comparison of CTC isolation and recovery with CellSearch system. (C) Molecular FISH analysis on enriched CTCs of a patient with NSCLC. Cells were stained using Vysis ALK Break Apart FISH probe and counterstained with DAPI. The red and green signals demonstrated a distinct separation of the original fusion signal (arrows), indicating a rearrangement in the 2p23 ALK-gene locus. Scale bar: 16 µm. (D) <t>MassArray</t> spectra for a patient with NSCLC harboring EGFR L747_P753>S. Trace from FFPE, plasma and pooled CTCs illustrated. Percentage indicates calculated proportion of mutant allele against wild type allele (UEP: Unextended primer). ( i ) iPlex bi-allelic spectra on FFPE sample (33% mutant frequency), ( ii ) iPlex bi-allelic spectrum on plasma sample (32% mutant frequency), ( iii ) SABER mutant specific spectrum on plasma sample (Positive – high frequency), ( iv ) SABER mutant specific spectrum on CTCs (Positive – low frequency (n = 3/94), estimated mutant frequency of 1.4%) and ( v ) Representative iPlex & SABER (shown) spectrum on no-template control sample (Negative).
Massarray Rs1000 Nanodispenser, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/massarray rs1000 nanodispenser/product/Sequenom
Average 90 stars, based on 1 article reviews
massarray rs1000 nanodispenser - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
384-format spectrochip ii  (Sequenom)
90
Sequenom 384-format spectrochip ii
(A) CTC viability demonstrated by attachment to 2D Geltrex (Invitrogen)-coated substrate (72 hr after seeding). Isolated CTC were enriched for CD44. No cells were stained for CD45, indicating the absence of WBCs which did not adhere to substrate and were removed after washing with 1X PBS. Some CD44+cells were not stained for Hoechst (white arrows). Scale bar: 20 µm (B) Comparison of CTC isolation and recovery with CellSearch system. (C) Molecular FISH analysis on enriched CTCs of a patient with NSCLC. Cells were stained using Vysis ALK Break Apart FISH probe and counterstained with DAPI. The red and green signals demonstrated a distinct separation of the original fusion signal (arrows), indicating a rearrangement in the 2p23 ALK-gene locus. Scale bar: 16 µm. (D) <t>MassArray</t> spectra for a patient with NSCLC harboring EGFR L747_P753>S. Trace from FFPE, plasma and pooled CTCs illustrated. Percentage indicates calculated proportion of mutant allele against wild type allele (UEP: Unextended primer). ( i ) iPlex bi-allelic spectra on FFPE sample (33% mutant frequency), ( ii ) iPlex bi-allelic spectrum on plasma sample (32% mutant frequency), ( iii ) SABER mutant specific spectrum on plasma sample (Positive – high frequency), ( iv ) SABER mutant specific spectrum on CTCs (Positive – low frequency (n = 3/94), estimated mutant frequency of 1.4%) and ( v ) Representative iPlex & SABER (shown) spectrum on no-template control sample (Negative).
384 Format Spectrochip Ii, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/384-format spectrochip ii/product/Sequenom
Average 90 stars, based on 1 article reviews
384-format spectrochip ii - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
spectrochip ® ii  (agena bioscience)
90
agena bioscience spectrochip ® ii
(A) CTC viability demonstrated by attachment to 2D Geltrex (Invitrogen)-coated substrate (72 hr after seeding). Isolated CTC were enriched for CD44. No cells were stained for CD45, indicating the absence of WBCs which did not adhere to substrate and were removed after washing with 1X PBS. Some CD44+cells were not stained for Hoechst (white arrows). Scale bar: 20 µm (B) Comparison of CTC isolation and recovery with CellSearch system. (C) Molecular FISH analysis on enriched CTCs of a patient with NSCLC. Cells were stained using Vysis ALK Break Apart FISH probe and counterstained with DAPI. The red and green signals demonstrated a distinct separation of the original fusion signal (arrows), indicating a rearrangement in the 2p23 ALK-gene locus. Scale bar: 16 µm. (D) <t>MassArray</t> spectra for a patient with NSCLC harboring EGFR L747_P753>S. Trace from FFPE, plasma and pooled CTCs illustrated. Percentage indicates calculated proportion of mutant allele against wild type allele (UEP: Unextended primer). ( i ) iPlex bi-allelic spectra on FFPE sample (33% mutant frequency), ( ii ) iPlex bi-allelic spectrum on plasma sample (32% mutant frequency), ( iii ) SABER mutant specific spectrum on plasma sample (Positive – high frequency), ( iv ) SABER mutant specific spectrum on CTCs (Positive – low frequency (n = 3/94), estimated mutant frequency of 1.4%) and ( v ) Representative iPlex & SABER (shown) spectrum on no-template control sample (Negative).
Spectrochip ® Ii, supplied by agena bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/spectrochip ® ii/product/agena bioscience
Average 90 stars, based on 1 article reviews
spectrochip ® ii - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
spectrochip® ii g96  (Sequenom)
90
Sequenom spectrochip® ii g96
(A) CTC viability demonstrated by attachment to 2D Geltrex (Invitrogen)-coated substrate (72 hr after seeding). Isolated CTC were enriched for CD44. No cells were stained for CD45, indicating the absence of WBCs which did not adhere to substrate and were removed after washing with 1X PBS. Some CD44+cells were not stained for Hoechst (white arrows). Scale bar: 20 µm (B) Comparison of CTC isolation and recovery with CellSearch system. (C) Molecular FISH analysis on enriched CTCs of a patient with NSCLC. Cells were stained using Vysis ALK Break Apart FISH probe and counterstained with DAPI. The red and green signals demonstrated a distinct separation of the original fusion signal (arrows), indicating a rearrangement in the 2p23 ALK-gene locus. Scale bar: 16 µm. (D) <t>MassArray</t> spectra for a patient with NSCLC harboring EGFR L747_P753>S. Trace from FFPE, plasma and pooled CTCs illustrated. Percentage indicates calculated proportion of mutant allele against wild type allele (UEP: Unextended primer). ( i ) iPlex bi-allelic spectra on FFPE sample (33% mutant frequency), ( ii ) iPlex bi-allelic spectrum on plasma sample (32% mutant frequency), ( iii ) SABER mutant specific spectrum on plasma sample (Positive – high frequency), ( iv ) SABER mutant specific spectrum on CTCs (Positive – low frequency (n = 3/94), estimated mutant frequency of 1.4%) and ( v ) Representative iPlex & SABER (shown) spectrum on no-template control sample (Negative).
Spectrochip® Ii G96, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/spectrochip® ii g96/product/Sequenom
Average 90 stars, based on 1 article reviews
spectrochip® ii g96 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
massarray compact analyzer  (Sequenom)
90
Sequenom massarray compact analyzer
(A) CTC viability demonstrated by attachment to 2D Geltrex (Invitrogen)-coated substrate (72 hr after seeding). Isolated CTC were enriched for CD44. No cells were stained for CD45, indicating the absence of WBCs which did not adhere to substrate and were removed after washing with 1X PBS. Some CD44+cells were not stained for Hoechst (white arrows). Scale bar: 20 µm (B) Comparison of CTC isolation and recovery with CellSearch system. (C) Molecular FISH analysis on enriched CTCs of a patient with NSCLC. Cells were stained using Vysis ALK Break Apart FISH probe and counterstained with DAPI. The red and green signals demonstrated a distinct separation of the original fusion signal (arrows), indicating a rearrangement in the 2p23 ALK-gene locus. Scale bar: 16 µm. (D) <t>MassArray</t> spectra for a patient with NSCLC harboring EGFR L747_P753>S. Trace from FFPE, plasma and pooled CTCs illustrated. Percentage indicates calculated proportion of mutant allele against wild type allele (UEP: Unextended primer). ( i ) iPlex bi-allelic spectra on FFPE sample (33% mutant frequency), ( ii ) iPlex bi-allelic spectrum on plasma sample (32% mutant frequency), ( iii ) SABER mutant specific spectrum on plasma sample (Positive – high frequency), ( iv ) SABER mutant specific spectrum on CTCs (Positive – low frequency (n = 3/94), estimated mutant frequency of 1.4%) and ( v ) Representative iPlex & SABER (shown) spectrum on no-template control sample (Negative).
Massarray Compact Analyzer, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/massarray compact analyzer/product/Sequenom
Average 90 stars, based on 1 article reviews
massarray compact analyzer - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
massarray nanodispenser rs1000  (agena bioscience)
90
agena bioscience massarray nanodispenser rs1000
(A) CTC viability demonstrated by attachment to 2D Geltrex (Invitrogen)-coated substrate (72 hr after seeding). Isolated CTC were enriched for CD44. No cells were stained for CD45, indicating the absence of WBCs which did not adhere to substrate and were removed after washing with 1X PBS. Some CD44+cells were not stained for Hoechst (white arrows). Scale bar: 20 µm (B) Comparison of CTC isolation and recovery with CellSearch system. (C) Molecular FISH analysis on enriched CTCs of a patient with NSCLC. Cells were stained using Vysis ALK Break Apart FISH probe and counterstained with DAPI. The red and green signals demonstrated a distinct separation of the original fusion signal (arrows), indicating a rearrangement in the 2p23 ALK-gene locus. Scale bar: 16 µm. (D) <t>MassArray</t> spectra for a patient with NSCLC harboring EGFR L747_P753>S. Trace from FFPE, plasma and pooled CTCs illustrated. Percentage indicates calculated proportion of mutant allele against wild type allele (UEP: Unextended primer). ( i ) iPlex bi-allelic spectra on FFPE sample (33% mutant frequency), ( ii ) iPlex bi-allelic spectrum on plasma sample (32% mutant frequency), ( iii ) SABER mutant specific spectrum on plasma sample (Positive – high frequency), ( iv ) SABER mutant specific spectrum on CTCs (Positive – low frequency (n = 3/94), estimated mutant frequency of 1.4%) and ( v ) Representative iPlex & SABER (shown) spectrum on no-template control sample (Negative).
Massarray Nanodispenser Rs1000, supplied by agena bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/massarray nanodispenser rs1000/product/agena bioscience
Average 90 stars, based on 1 article reviews
massarray nanodispenser rs1000 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


(A) CTC viability demonstrated by attachment to 2D Geltrex (Invitrogen)-coated substrate (72 hr after seeding). Isolated CTC were enriched for CD44. No cells were stained for CD45, indicating the absence of WBCs which did not adhere to substrate and were removed after washing with 1X PBS. Some CD44+cells were not stained for Hoechst (white arrows). Scale bar: 20 µm (B) Comparison of CTC isolation and recovery with CellSearch system. (C) Molecular FISH analysis on enriched CTCs of a patient with NSCLC. Cells were stained using Vysis ALK Break Apart FISH probe and counterstained with DAPI. The red and green signals demonstrated a distinct separation of the original fusion signal (arrows), indicating a rearrangement in the 2p23 ALK-gene locus. Scale bar: 16 µm. (D) MassArray spectra for a patient with NSCLC harboring EGFR L747_P753>S. Trace from FFPE, plasma and pooled CTCs illustrated. Percentage indicates calculated proportion of mutant allele against wild type allele (UEP: Unextended primer). ( i ) iPlex bi-allelic spectra on FFPE sample (33% mutant frequency), ( ii ) iPlex bi-allelic spectrum on plasma sample (32% mutant frequency), ( iii ) SABER mutant specific spectrum on plasma sample (Positive – high frequency), ( iv ) SABER mutant specific spectrum on CTCs (Positive – low frequency (n = 3/94), estimated mutant frequency of 1.4%) and ( v ) Representative iPlex & SABER (shown) spectrum on no-template control sample (Negative).

Journal: PLoS ONE

Article Title: Clinical Validation of an Ultra High-Throughput Spiral Microfluidics for the Detection and Enrichment of Viable Circulating Tumor Cells

doi: 10.1371/journal.pone.0099409

Figure Lengend Snippet: (A) CTC viability demonstrated by attachment to 2D Geltrex (Invitrogen)-coated substrate (72 hr after seeding). Isolated CTC were enriched for CD44. No cells were stained for CD45, indicating the absence of WBCs which did not adhere to substrate and were removed after washing with 1X PBS. Some CD44+cells were not stained for Hoechst (white arrows). Scale bar: 20 µm (B) Comparison of CTC isolation and recovery with CellSearch system. (C) Molecular FISH analysis on enriched CTCs of a patient with NSCLC. Cells were stained using Vysis ALK Break Apart FISH probe and counterstained with DAPI. The red and green signals demonstrated a distinct separation of the original fusion signal (arrows), indicating a rearrangement in the 2p23 ALK-gene locus. Scale bar: 16 µm. (D) MassArray spectra for a patient with NSCLC harboring EGFR L747_P753>S. Trace from FFPE, plasma and pooled CTCs illustrated. Percentage indicates calculated proportion of mutant allele against wild type allele (UEP: Unextended primer). ( i ) iPlex bi-allelic spectra on FFPE sample (33% mutant frequency), ( ii ) iPlex bi-allelic spectrum on plasma sample (32% mutant frequency), ( iii ) SABER mutant specific spectrum on plasma sample (Positive – high frequency), ( iv ) SABER mutant specific spectrum on CTCs (Positive – low frequency (n = 3/94), estimated mutant frequency of 1.4%) and ( v ) Representative iPlex & SABER (shown) spectrum on no-template control sample (Negative).

Article Snippet: Cleaned PCR product was spotted onto MassArray SpectroCHIPS II (Sequenom) using the MassARRAY RS1000 Nanodispenser.

Techniques: Isolation, Staining, Comparison, Clinical Proteomics, Mutagenesis, Control